HALO HALOZYME THERAPEUTICS INC
FollowStock (common), issuer CIK 1159036
Filings received so far for Q3 2026: 31 13F filers report a position in HALO shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
| Owner | Date | Shares | Price | Filing |
|---|---|---|---|---|
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-08 | -200 S | $110.51 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-08 | -11,900 S | $109.995 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-08 | -3,090 S | $108.908 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-08 | -4,810 S | $108.179 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-08 | +20,000 M | $18.41 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-07 | -200 S | $113.693 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-07 | -900 S | $112.78 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-07 | -10,300 S | $111.839 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-07 | -8,600 S | $111.031 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-07 | +20,000 M | $18.41 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-06 | -1,780 S | $110.812 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-06 | -9,920 S | $109.891 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-06 | -6,000 S | $109.334 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-06 | -2,300 S | $107.902 | Form 4 |
| Torley Helendirector, officer (PRESIDENT AND CEO) | 2026-10-06 | +20,000 M | $18.41 | Form 4 |
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
Torley Helen reported transactions in HALO shares with no net change in a Form 4 filed 2026-10-08. 0001159036-26-000140
Accepted , ingestedConnaughton Bernadette acquired 3,796 HALO shares on 2026-05-05, Form 4/A filed 2026-10-08. 0001159036-26-000139
Accepted , ingested